8/18/2019 Novartis AG v. UOI

1/16

UNIVERSITY OF PETROLEUM & ENERGY STUDIES

COLLEGE OF LEGAL STUDIES

B.B.A., LL.B (HONS.)

SEMESTER  VIII

ACADEMIC YEAR: 2015-2016 SESSION: JANUARY-MAY

NOVARTIS AG v. UNION OF INDIA & OTHERS

‘Evergreening’: A !""#e $e%een Prive M'n'('#) n* Inn'vi'n

FOR 

S!$+e, N-e: Ine##e,!# Pr'(er Rig"

Un*er e S!(ervi"i'n '/: A"". Pr'/. An!r* N)0 

 NAME: SHREYA SINGH (500022285)-R OLL NO.: R76021207

!RIYANSHU SHRI"AS#A" (50002$%71)

!RANAY !RA#A! SINGH (50002268)

1

8/18/2019 Novartis AG v. UOI

2/16

TA1LE OF CONTENTS

I. INTRODUCTION&&&&&&&&&&&&&&&&&&&&&&..$

II. CASE ANALYSIS.&&&&&&&&&&&&&&&&&&&&&&$-7

1.1 '*+ */ +/

1.2 I++/+:

1.$ A3/4*+:

1.$.1 C4*/4*4+ */ /4*

1.$.2 C4*/4*4+ */ R/+4/4*:

1. J3/4*:

1.5 H/:

III. CRITICAL ANALYSIS OF THE 2UDGMENT&&&&&&&&&&..7

IV. RESEARCH 3UESTIONS&&&&&&&&&&&&&&&&&&&&.8

1. #/ 3* */4* /3/ 4 4*/ /+ +.

2. 9/*/ S/*4 $() */ !*/4* A*, 1%70 + 4 34/ * #RI!S

1. 9/*/ */ */4* + +* * * 43;/ 4*

8/18/2019 Novartis AG v. UOI

3/16

8/18/2019 Novartis AG v. UOI

4/16

H'n>$#e 2!*ge":

A/$ A#-? Rn+nPr0" De"i?22.

C'!n"e#":

' A/4*: GS;343 4 #. R. A4=4.

' R/+4/4*+: !+

S!$+e,: Pen"

A,"=R!#e"=Or*er": +/*4 $() */ !*/4*+ A*, 1%70, +/*4 2 (1)() / * +/*4 1$$ */

A*, +/*4 2A */ A*, +/*4 25(1) */ A*, / 55 */ !*/4* R/+, 200$, A*/ 1 */

C4+***4 I4, A*/ 27 4 A*/ 6 */ #RI!S A//3/4*.

7.7 F," '/ e ,"e:

 N

8/18/2019 Novartis AG v. UOI

5/16

8/18/2019 Novartis AG v. UOI

6/16

I */ *+

8/18/2019 Novartis AG v. UOI

7/16

7.8.5 C'neni'n" '/ e Re"('n*en:

#* */ ;/* =+*4/ +* */ 34 + 4/*/ 4

8/18/2019 Novartis AG v. UOI

8/16

H/

8/18/2019 Novartis AG v. UOI

9/16

4 */// */ !*/4*+ (A3/43/4*) B + 4/ ;= */ L S; 4 R= S; 4 M

*/4*= * 4 M */4*= *//, 2005, +/

8/18/2019 Novartis AG v. UOI

10/16

PRO1LEMS THAT INDIAN PATENTS COULD FACE

A+ 4/ */ / *4+ / 4* // 4 */// */ 4/ */4*+ / 4* /, /+=

4*/ /4/+ *4 */ I44 3/* / 4* * ;/ */4 ; *

8/18/2019 Novartis AG v. UOI

11/16

4+/ */ 4*/4*4 / 4+*3/4*+ */// 4 34+*/ +/ * 34/

8/18/2019 Novartis AG v. UOI

12/16

O4*4@+ (9#O) 3433 +*4+ 4*//* /*= */*4,10 ;* *+ */4* + +*

* * 43;/ 4*

8/18/2019 Novartis AG v. UOI

13/16

+;+*4/ + ;/ 4+// * ;/ */ +3/ +;+*4/, 4/++ */= / +44*= 4 /*/+ *

/ * /=. #+ 4*

8/18/2019 Novartis AG v. UOI

14/16

4*/+ + + S4/ C4 /4 4

8/18/2019 Novartis AG v. UOI

15/16

8/18/2019 Novartis AG v. UOI

16/16

1. 'ERO ALI HADER, #HE LA9 O' !A#EN#S- 9I#H A S!ECIAL 'OCUS ON

!HARMACEU#ICALS IN INDIA, (L/+N/+ 2011) (200%)

Cases referred for case analysis-

1. U* C4**+ 4 J4/= !